Further, we present a comprehensive analysis of the mechanism underlying maintenance of the stemness properties of CD44v6+ HCC cells via the HGF/MET signaling pathway and provide the first evidence of for a specific cJun binding site. This evidence concerns the gene MET and hepatocellular carcinoma.